Treatment of Tinea Pedis (Athlete's Foot)
Topical terbinafine 1% cream applied twice daily for 1 week is the first-line treatment for tinea pedis due to its high efficacy and convenient dosing regimen. 1, 2
First-Line Topical Treatment Options
- Terbinafine 1% cream should be applied twice daily for 1 week for interdigital tinea pedis (between the toes) and for 2 weeks for plantar tinea pedis (bottom or sides of the foot) 2
- Ciclopirox olamine 0.77% cream/gel is highly effective, achieving approximately 85% mycological cure two weeks after treatment, and is superior to clotrimazole 1% cream 3, 1
- Before applying any topical treatment, wash and thoroughly dry the affected area 2
- Treatment should continue for at least one week after clinical clearing of infection to prevent recurrence 4
Treatment Algorithm Based on Presentation
Interdigital (between toes) tinea pedis:
Plantar/moccasin-type (bottom/sides of foot) tinea pedis:
Vesiculobullous (inflammatory) tinea pedis:
- Consider oral therapy due to more severe presentation 5
Oral Therapy for Severe or Resistant Cases
- Oral therapy is indicated for severe disease, failed topical therapy, extensive infection, immunocompromised patients, or concomitant onychomycosis 6, 5
- Oral terbinafine 250 mg once daily for 1 week provides faster clinical resolution than topical treatments with similar efficacy to 4 weeks of clotrimazole 1% cream 3, 1
- Oral itraconazole 100 mg daily for 2 weeks is an alternative but may have a slightly higher relapse rate compared to terbinafine 3, 1
Prevention Measures
- Thoroughly dry between toes after bathing/showering 3
- Apply foot powder after bathing (reduces tinea pedis rates from 8.5% to 2.1%) 3, 1
- Change socks daily and clean athletic footwear periodically 3, 6
- Wear well-fitting, ventilated shoes 2
- To prevent spread to the groin area (tinea cruris), cover active foot lesions with socks before wearing underwear 3
Common Pitfalls and Caveats
- Clinical diagnosis alone is unreliable as tinea pedis has many mimics; confirm diagnosis with potassium hydroxide preparation or culture in uncertain cases 5, 7
- Failing to treat for the full recommended duration can lead to recurrence; treatment should continue for at least one week after clinical clearing 4
- Neglecting to address contaminated footwear as a source of reinfection can lead to recurrence 6
- Risk factors that should prompt more aggressive treatment include diabetes, obesity, and immunocompromised status 3, 1
- Single-dose terbinafine 1% film-forming solution has shown efficacy (63% effective treatment at 6 weeks) but has a 12.5% recurrence rate at 3 months 8